Quantcast
Last updated on April 16, 2014 at 1:21 EDT

Latest sarcomas Stories

2014-02-12 23:25:02

ION Solutions, a diversified physician services organization whose membership represents more than half of the private practice oncologists in the United States, today announced the selection of Foundation Medicine as its preferred partner for comprehensive cancer genomic profiling services. Frisco, Texas (PRWEB) February 12, 2014 ION Solutions, a diversified physician services organization whose membership represents more than half of the private practice oncologists in the United...

2013-07-09 16:01:45

Orthopedic oncologists and surgical oncologists, who have been trained in the complex procedures required to remove sarcomas located deep in the muscles and other soft tissues of the limbs, conducted only 52 percent of these operations at 85 academic medical centers during a three year period, according to an analysis of national data by UC Davis researchers that is published online today in the Journal of Surgical Oncology. The remaining 48 percent of these sarcoma surgeries were...

2013-02-11 15:42:02

Nobel Laureate Mario R. Capecchi leads collaboration of researchers Geneticists led by University of Utah Nobel Prize Laureate Mario R. Capecchi, Ph.D., have engineered mice that develop clear cell sarcoma (CCS), a significant step in better understanding how this rare and deadly soft tissue cancer arises. The mouse model also can potentially speed the development of drugs to target genes that must be activated for the cancer to form. CCS arises in connective soft tissues, such as...

2011-12-03 11:08:04

MK 1775, a small, selective inhibitor molecule, has been found to be active against many sarcomas when tested by researchers at Moffitt Cancer Center in Tampa, Fla. Their findings, recently appearing in Molecular Cancer Therapeutics, published by the American Association for Cancer Research, suggest that a badly needed new agent against sarcomas - especially sarcomas affecting children - may be at hand. According to corresponding author Soner Altiok, M.D., Ph.D., sarcomas are rare forms of...

2010-03-08 12:53:39

ESMO Conference on Sarcoma and GIST New breakthrough treatments for the most common cancers could soon come from cutting-edge research into some of the world's rarest tumors. At the ESMO Conference on Sarcoma and GIST, to be held in Milan, Italy, on 9 and 10 March 2010, researchers and some of the world's leading experts will discuss exciting new science on sarcomas"”a group of rare tumors found in muscle, blood vessels, deep skin tissues, nerves and the tissues around joints. Although...

2009-11-06 08:00:00

CALGARY, Nov. 6 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. (TSX:ONC, NASDAQ:ONCY) ("Oncolytics" or the "Company") today announced updated results from a Phase II study of intravenous REOLYSIN(R) in patients with sarcomas metastatic to the lung in a poster presentation at the 15th Annual Connective Tissue Oncology Society Meeting held in Miami Beach, Florida, from November 5th to 7th. The poster presentation, entitled "A Phase II Study of Intravenous REOLYSIN (Wild-type Reovirus) in the...

2009-10-13 12:07:15

Researchers at UCLA's Jonsson Comprehensive Cancer Center showed for the first time that the loss or decreased expression of the tumor suppressor gene PTEN plays a central role in the malignant transformation of benign nerve tumors called neurofibromas into a malignant and extremely deadly form of sarcoma. The work, a collaboration between the Institute for Molecular Medicine, the Department of Molecular and Medical Pharmacology and the cancer center's Sarcoma Program, could lead to the...

2009-09-07 14:18:57

XMRV retrovirus is associated with more aggressive tumors In a finding with potentially major implications for identifying a viral cause of prostate cancer, researchers at the University of Utah and Columbia University medical schools have reported that a type of virus known to cause leukemia and sarcomas in animals has been found for the first time in malignant human prostate cancer cells. If further investigation proves the virus, XMRV (Xenotropic murine leukemia virus-related virus),...

2008-07-16 03:00:16

By Dishop, Megan K Kuruvilla, Supriya * Context.-Primary lung neoplasms are rare in children, but they comprise a broad and interesting spectrum of lesions, some of which are familiar from other tissue sites, and some of which are unique to the pediatric lung. Objective.-To determine the relative incidence of primary and metastatic lung tumors in children and adolescents through a single-institution case series, to compare these data to reports in the medical literature, to discuss the...